- All
- #InspiredByLife
- Bioeconomy
- Biosimilars
- BREXIT
- Cell & Gene Therapies
- Circular Economy
- Climate Change
- COVID-19
- Factsheet
- Genome editing
- HEALTHCARE BIOTECH
- INDUSTRIAL BIOTECH
- Innovation
- Intellectual Property
- Interview
- Jobs & Growth
- NATIONAL ASSOCIATIONS
- News
- Other
- Patient Bio-Forum
- Position Paper
- Press release
- Public Procurement
- Regulatory Efficiency
- Report
- SME
- SME Platform
- WHAT IF
- White paper
September 30, 2021
What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?
August 27, 2021
EuropaBio comments on the public consultation on blue bioeconomy.
August 10, 2021
EuropaBio comments on the public consultation on blue bioeconomy.
June 29, 2021
We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
May 26, 2021
May 20, 2021
The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
May 5, 2021
EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation.
May 5, 2021
EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation.
May 5, 2021
EuropaBio Statement – Vaccine production scale up: International collaboration remains the key.
April 16, 2021
March 5, 2021
March 1, 2021
Read EuropaBios interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi, on the occasion of Rare Disease Week 2021.
February 24, 2021
On February 24th, EuropaBio submitted its feedback to the HERA Consultation.
February 4, 2021
EuropaBio welcomes the European Commission’s plan to begin a discussion with stakeholders to develop the EHDS.
January 29, 2021
EuropaBio welcomes the European Health Union plan. The EU has indeed a critical role to play in public health and better crisis preparedness to address serious cross-border health threats and improving crisis management capacity.
